https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b93fae8e-2b76-421e-95bc-ba08c211a7ea
DailyMed - PALONOSETRON injection, solution
dailymedpalonosetroninjectionsolution
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9132366b-b808-46c9-b167-c1900bc116b3&type=display
These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE...
all the information
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/16714-0834/
16714-0834 Palonosetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
palonosetronndc
https://www.cancer.gov/about-cancer/treatment/drugs/palonosetronhydrochloride
Palonosetron Hydrochloride - NCI
This page contains brief information about palonosetron hydrochloride and a collection of links to more information about the use of this drug, research...
palonosetronhydrochloridenci
https://www.ncbi.nlm.nih.gov/Structure/pdb/6Y1Z
6Y1Z: Mouse serotonin 5HT3 receptor in complex with palonosetron
5-hydroxytryptamine receptor...
mouseserotoninreceptorcomplexpalonosetron
https://clinicaltrials.stanford.edu/trials/p/NCT00661674.html
Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
palonosetronhydroxyzinereduceopioidwithdrawal
https://adisinsight.springer.com/patents/800032259
Netupitant/palonosetron - Helsinn - AdisInsight
palonosetronadisinsight
https://www.cancer.gov/about-cancer/treatment/drugs/netupitant-palonosetronhydrochloride
Netupitant and Palonosetron Hydrochloride - NCI
This page contains brief information about netupitant and palonosetron hydrochloride and a collection of links to more information about the use of this...
palonosetronhydrochloridenci
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a7
DailyMed - POSFREA- palonosetron injection, solution
dailymedpalonosetroninjectionsolution
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/23155-0356/
23155-0356 Palonosetron Hydrochloride - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
palonosetronhydrochloridendc
https://pubmed.ncbi.nlm.nih.gov/23644992/?dopt=Abstract
The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced...
Triplet antiemetic therapy using a 0.75-mg dose of palonosetron shows a promising antiemetic effect in preventing CINV in lung cancer patients receiving HEC.
https://pubmed.ncbi.nlm.nih.gov/20552375/?dopt=Abstract
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients...
This study shows that palonosetron in combination with aprepitant and dexamethasone is effective to prevent chemotherapy-induced nausea and vomiting in...
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/67457-0317/
67457-0317 Palonosetron Hydrochloride - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
palonosetronhydrochloridendc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b93fae8e-2b76-421e-95bc-ba08c211a7ea&audience=consumer
DailyMed - PALONOSETRON injection, solution
dailymedpalonosetroninjectionsolution
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9132366b-b808-46c9-b167-c1900bc116b3&audience=consumer
DailyMed - PALONOSETRON injection, solution
dailymedpalonosetroninjectionsolution